FOCUS-Takeda CEO prescribes surgical R&D cuts after $62 bln Shire deal
May 17, 2018 at 08:10 AM EDT
* Takeda boss to raise bar for pipeline drugs after Shire deal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|